Patient and practitioner perceptions around use of artificial intelligence within the English NHS diabetic eye screening programme.

Aims: Automated retinal image analysis using Artificial Intelligence (AI) can detect diabetic retinopathy as accurately as human graders, but it is not yet licensed in the NHS Diabetic Eye Screening Programme (DESP) in England. This study aims to assess perceptions of People Living with Diabetes (PLD) and Healthcare Practitioners (HCP) towards AI's introduction in DESP.

Methods: Two online surveys were co-developed with PLD and HCP from a diverse DESP in North East London.

Implementation challenges of artificial intelligence (AI) in primary care: Perspectives of general practitioners in London UK.

Introduction: Implementing artificial intelligence (AI) in healthcare, particularly in primary care settings, raises crucial questions about practical challenges and opportunities. This study aimed to explore the perspectives of general practitioners (GPs) on the impact of AI in primary care.

Methods: A convenience sampling method was employed, involving a hybrid workshop with 12 GPs and 4 GP registrars.

Residential exposure to spp is associated with exacerbations in COPD.

Background: Sensitisation to is linked to worse outcomes in patients with COPD; however, its prevalence and clinical implications in domestic (residential) settings remains unknown.

Methods: Individuals with COPD (n=43) recruited in Singapore had their residences prospectively sampled and assessed by shotgun metagenomic sequencing including indoor air, outdoor air and touch surfaces (a total of 126 specimens). The abundance of environmental and the occurrence of (Asp f) allergens in the environment were determined and immunological responses to allergens determined in association with clinical outcomes including exacerbation frequency.

Effects of a live versus heat-inactivated probiotic spp in preterm infants: a randomised clinical trial.

Background: Heat-inactivated probiotics (HPs) may provide an effective alternative to live probiotics (P) by avoiding their risks (eg, probiotic sepsis) while retaining the benefits. We assessed the safety and efficacy of a HP in very preterm (VP: gestation <32 weeks) infants.

Methods: VP infants were randomly allocated to receive a HP or P mixture ( M-16V, subsp.

BECC-engineered live-attenuated vaccine candidates display reduced endotoxicity with robust immunogenicity in mice.

. infection contributes significantly to the global disease burden, primarily affecting young children in developing countries. Currently, there are no FDA-approved vaccines against and the prevalence of antibiotic resistance is increasing, making therapeutic options limited.